#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Neuroendocrine carcinoma of the skin Inflammatory myofibroblastic tumour Neuroblastoma recurrent Small for dates baby Central nervous system lymphoma Demyelination Splenic marginal zone lymphoma Craniopharyngioma Conjunctivitis allergic Basal cell naevus syndrome Myelodysplastic syndrome Ventricular tachycardia Crigler-Najjar syndrome Univentricular heart More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Trials in Disease Vascular malformation – Basic Information Factor IX deficiency Paroxysmal nocturnal haemoglobinuria – Life with Disease Bronchopulmonary dysplasia – Trials in Disease Anaplastic thyroid cancer – Diagnostics Carcinoid syndrome – Basic Information Glycogen storage disease type V – Basic Information Pituitary-dependent Cushing’s syndrome – Basic Information Hereditary optic atrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ILOPROST Litenimod Sodium Loperamide Hydrochloride Mavorixafor Tenofovir Disoproxil Fumarate GSKVX000000070250 64CU-PSMA I&T Napabucasin Cyclophosphamide Monohydrate Cx-039776 Air, Medicinal Inupadenant Vildagliptin COLESEVELAM HYDROCHLORIDE Bi 3032950 Epirubicin Hydrochloride Glycerol Phenylbutyrate Betamethasone Pivekimab Sunirine Vsf1.01 More therapies…

    Learn about Your Condition

    Invasive breast carcinoma Lichen planus Wolfram syndrome Acromegaly Post-traumatic stress disorder Ehlers-Danlos syndrome Haemorrhage prophylaxis Device related infection Rectal cancer Eye disorder Synovial sarcoma recurrent Optic ischaemic neuropathy Asthma Colour blindness Tinnitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

  • A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

    Not yet recruiting

    3 1
    Belgium France Germany Ireland Italy Poland +2

  • Effect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Semaglutide
    Italy

  • A study to assess the safety of RJVA-001 in adults with type 2 diabetes that is not well controlled by current medications.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS SEROTYPE 9 CONTAINING THE HUMAN GCG GENE
    The Netherlands

  • A study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Germany The Netherlands Spain

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    • Osteomyelitis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Cefalexin Monohydrate
    • Clindamycin
    Finland
Previous Page
1 … 24 25 26 27 28 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!